Log in to save to my catalogue

MERTK receptor tyrosine kinase is a therapeutic target in melanoma

MERTK receptor tyrosine kinase is a therapeutic target in melanoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3639697

MERTK receptor tyrosine kinase is a therapeutic target in melanoma

About this item

Full title

MERTK receptor tyrosine kinase is a therapeutic target in melanoma

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2013-05, Vol.123 (5), p.2257-2267

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Metastatic melanoma is one of the most aggressive forms of cutaneous cancers. Although recent therapeutic advances have prolonged patient survival, the prognosis remains dismal. C-MER proto-oncogene tyrosine kinase (MERTK) is a receptor tyrosine kinase with oncogenic properties that is often overexpressed or activated in various malignancies. Using...

Alternative Titles

Full title

MERTK receptor tyrosine kinase is a therapeutic target in melanoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3639697

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3639697

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI67816

How to access this item